Editorials and Opinions

A rare disease patient/caregiver perspective on fair pricing and access to gene-based therapies.

Real-world evidence is derived from curating, standardizing, and analyzing real-world data to obtain high-quality and reliable information from diverse and complex sources.

Big Pharma Hikes Drug Prices in Midst of COVID-19 Crisis.

The use of data from the real world to address clinical and policy-relevant questions that cannot be answered using data from clinical trials is garnering increased interest.

The Orphan Drug Act extends exclusivity of branded drugs by 7 years for each rare disease approval.

The age of high revenue generating blockbuster drugs.

The social determinants of health (SDOH) are the social and economic factors that influence people's health.

Over a thousand clinical trials have been halted by the coronavirus.

What do Americans get for paying premium prices for decades?

To what extent have manufacturer discounts offset increases in list prices of branded pharmaceutical products in the US?

A Look at Pharma Industry Alternatives

How much does it costs to develop a new drug -- start to finish?

The devil is in the details.

The United States ranks number-one in the world for cost of vital medicines.

In medicine, spending more is not always better.